CLS B — Clinical Laserthermia Systems AB Share News
0.000.00%
Last trade - 00:00- SEK90.69m
- SEK83.48m
- SEK17.49m
Brief: Clinical Laserthermia Appoints Katarina Lundqvist As Permanent CFO
Brief: CLS Announces Outcome In Rights Issue Of Units
Brief: CLS Agrees On Top-Down Guarantee For Rights Issue
Brief: CLS Conducts Rights Issue Of SEK 39.5 Million
Brief: CLS Resolves On Rights Issue Of Units Up To SEK 39.5 Mln
Brief: CLS Q2 Operating Loss Widens To SEK 13.6 Mln
Brief: CLS Enters Research Agreement With U.S. National Cancer Institute
Sweden's CLS Q1 sales fall 72% after partner talks
Brief: Clinical Laserthermia Systems Q1 EBIT Sek 1.7 Mln
Brief: CLS Receives Order Worth SEK 23 Mln For Prism Business
Brief: CLS Expects To Achieve Positive Cash Flow From Q4 2026 To Q1 2028
Brief: Clinical Laserthermia Systems Says Continues To Maintain Targets For 2026
Brief: CLS Initiates Recruitment Process For Permanent Chief Financial Officer
Brief: Clinical Laserthermia Systems Q3 Revenue SEK 2.8 Mln
Brief: CLS Raises SEK 20.9 Mln Through Full Subscription Of Warrants
Brief: Clinical Laserthermia Systems Gets FDA Clearance For Expanded Labeling
Brief: CLS H1 Oper Loss At SEK 10.8 Mln
Brief: Clinical Laserthermia Systems Q1 Basic EPS SEK -0.68
Brief: Clinical Laserthermia Systems To Carry Out A Directed Issue Of 5.5 Mln Units